Future Fund Weighs Up AI Productivity Riddle

Mr Samild will participate in Friday’s macro panel at the prestigious Sohn Hearts & Minds conference, along with Sheila Patel and Atul Lele.
Future Fund CIO Ben Samild: It will change the way we interact with each other and potentially have a big impact on the economy. Picture: NCA Newswire / Nicki Connolly

David Rogers

Future Fund Weighs Up AI Productivity Riddle

November 16, 2023
Mr Samild will participate in Friday’s macro panel at the prestigious Sohn Hearts & Minds conference, along with Sheila Patel and Atul Lele.
Read Transcript

A year on from the ChatGPT revolution, the $200bn Future Fund is still on the sidelines of the AI revolution, as it weighs up how the technology might transform the global economy.

“There’s a wide market for the impact of this technology on productivity,” Future Fund chief investment officer Ben Samild tells The Australian. “It will change the way we interact with each other and potentially have a big impact on the economy.”

If the $205bn sovereign wealth fund takes a view on the macro­economic impact of the technology that has boosted the US share market over the past year, he sees many ways it can exploit it.

Mr Samild will participate in Friday’s macro panel at the prestigious Sohn Hearts & Minds conference, along with Sheila Patel, the vice-chair of B Capital Group and former chair of Goldman Sachs Asset Management, and Atul Lele, senior portfolio strategist at Bridgewater Associates. Many investors now believe AI will unleash a “1990s-style productivity boom”.

Goldman Sachs predicts AI will start having a measurable impact on US GDP in 2027 and begin affecting growth in other economies around the world in the years that follow.

That is based on its finding that AI could ultimately automate about 25 per cent of labour tasks in advanced economies and 10-20 per cent of work in emerging economies.

AI will lift US productivity growth by 1.5 percentage points annually, assuming widespread adoption over a 10-year period, with similar effects in other advanced economies, the US bank says.

There are alternative views that AI might drag on productivity by narrowing the skills base, and threatening cognitive development and people’s ability to distinguish truth from falsity.

But if the Future Fund does come to a view that AI enhances productivity, it will influence its long-term outlook for nominal and real interest rates and ­inflation.

“That impacts on valuations, which sectors we might go into, whether we like – at a high level – investments like data centres versus something more traditional, like infrastructure,” Mr Samild said.

Just who captures the potential gains from AI is now a key question on his mind.

That will affect the fund’s thinking on whether it needs to be involved at the venture capital disruption level, or whether it backs the “mega-tech monopolies” in a situation where AI “just perpetuates the current trend of the “monopolisation of the economy” by the tech giants.

The so-called Magnificent Seven US tech companies already make up over 30 per cent of the S&P 500.

They have contributed nearly all of its year-to-date gain of around 17 per cent.

The combined weight of these companies is now greater than that of any of the top seven companies in the S&P 500 Index since before the turn of the 21st century, according to BlackRock.

“It’s not clear to us that we have to be first in this thing and in any case we still have exposure to it,” Mr Samild said. “If it’s this huge productivity boost that keeps inflation down, keeps interest rates pinned and it’s great for corporate profits, well that will be incredibly helpful to our portfolio.

“But if it requires a mountain of spending, leaves a whole lot of skilled people without employment needing to retrain, and undermines government income, then it’s contributing massively to inflation, hurting the fiscal position of governments, and you can imagine interest rates going up further.

“That would be terrible for us.

“Either way, we own a global portfolio and we have to steer it gently.”

‘There’s a wide market for the impact of this technology on productivity’

Ben Samild, Future Fund CIO


As for how much of the Magnificent Seven the Future Fund wants to own, Mr Samild points out that it already has exposure via active managers who can have concentrated positions in those stocks, as well as hedge funds that can do the same, and also run short positions.

But it can also benefit from second and third derivative impacts, particularly via increased demand for data centres, and clean energy, both of which have been very profitable for the Future Fund.

“We think the impact of AI will be pervasive, and anything that is pervasive seeps right through the value chain,” Mr Samild added.

“There are multiple ways to invest … they won’t be equally attractive at every point and parts of the system that need liquidity the most will tend to offer the best value.

“That’s really our function in the system – providing liquidity in places where it’s a bit harder to come by, supporting viable businesses.”

Sohn Hearts & Minds will reveal stock picks from leading investment experts all over the globe.

It was on track to have raised $60m by November, and all profits will go to medical research.

The Australian is a media partner of Sohn Hearts & Minds which will be held at the Sydney Opera House this Friday, November 17.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

A year on from the ChatGPT revolution, the $200bn Future Fund is still on the sidelines of the AI revolution, as it weighs up how the technology might transform the global economy.

“There’s a wide market for the impact of this technology on productivity,” Future Fund chief investment officer Ben Samild tells The Australian. “It will change the way we interact with each other and potentially have a big impact on the economy.”

If the $205bn sovereign wealth fund takes a view on the macro­economic impact of the technology that has boosted the US share market over the past year, he sees many ways it can exploit it.

Mr Samild will participate in Friday’s macro panel at the prestigious Sohn Hearts & Minds conference, along with Sheila Patel, the vice-chair of B Capital Group and former chair of Goldman Sachs Asset Management, and Atul Lele, senior portfolio strategist at Bridgewater Associates. Many investors now believe AI will unleash a “1990s-style productivity boom”.

Goldman Sachs predicts AI will start having a measurable impact on US GDP in 2027 and begin affecting growth in other economies around the world in the years that follow.

That is based on its finding that AI could ultimately automate about 25 per cent of labour tasks in advanced economies and 10-20 per cent of work in emerging economies.

AI will lift US productivity growth by 1.5 percentage points annually, assuming widespread adoption over a 10-year period, with similar effects in other advanced economies, the US bank says.

There are alternative views that AI might drag on productivity by narrowing the skills base, and threatening cognitive development and people’s ability to distinguish truth from falsity.

But if the Future Fund does come to a view that AI enhances productivity, it will influence its long-term outlook for nominal and real interest rates and ­inflation.

“That impacts on valuations, which sectors we might go into, whether we like – at a high level – investments like data centres versus something more traditional, like infrastructure,” Mr Samild said.

Just who captures the potential gains from AI is now a key question on his mind.

That will affect the fund’s thinking on whether it needs to be involved at the venture capital disruption level, or whether it backs the “mega-tech monopolies” in a situation where AI “just perpetuates the current trend of the “monopolisation of the economy” by the tech giants.

The so-called Magnificent Seven US tech companies already make up over 30 per cent of the S&P 500.

They have contributed nearly all of its year-to-date gain of around 17 per cent.

The combined weight of these companies is now greater than that of any of the top seven companies in the S&P 500 Index since before the turn of the 21st century, according to BlackRock.

“It’s not clear to us that we have to be first in this thing and in any case we still have exposure to it,” Mr Samild said. “If it’s this huge productivity boost that keeps inflation down, keeps interest rates pinned and it’s great for corporate profits, well that will be incredibly helpful to our portfolio.

“But if it requires a mountain of spending, leaves a whole lot of skilled people without employment needing to retrain, and undermines government income, then it’s contributing massively to inflation, hurting the fiscal position of governments, and you can imagine interest rates going up further.

“That would be terrible for us.

“Either way, we own a global portfolio and we have to steer it gently.”

‘There’s a wide market for the impact of this technology on productivity’

Ben Samild, Future Fund CIO


As for how much of the Magnificent Seven the Future Fund wants to own, Mr Samild points out that it already has exposure via active managers who can have concentrated positions in those stocks, as well as hedge funds that can do the same, and also run short positions.

But it can also benefit from second and third derivative impacts, particularly via increased demand for data centres, and clean energy, both of which have been very profitable for the Future Fund.

“We think the impact of AI will be pervasive, and anything that is pervasive seeps right through the value chain,” Mr Samild added.

“There are multiple ways to invest … they won’t be equally attractive at every point and parts of the system that need liquidity the most will tend to offer the best value.

“That’s really our function in the system – providing liquidity in places where it’s a bit harder to come by, supporting viable businesses.”

Sohn Hearts & Minds will reveal stock picks from leading investment experts all over the globe.

It was on track to have raised $60m by November, and all profits will go to medical research.

The Australian is a media partner of Sohn Hearts & Minds which will be held at the Sydney Opera House this Friday, November 17.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 16, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.